From: Vitamin C administration in the critically ill: a summary of recent meta-analyses
Publication details | Title | Selection criteria (PICO) | Included studies | Subgroup analysis | Findings |
---|---|---|---|---|---|
Putzu et al. [3] Crit Care Med | The effect of vitamin C on clinical outcome in critically ill patients: A systematic review with meta-analysis of randomised controlled trials | P—adult critically ill patients I—vitC (any regimen) C—placebo or no therapy O—mortality, acute kidney injury, supraventricular arrhythmia, ventricular arrhythmia, stroke, ICU LOS, hospital LOS | 44 RCTs: 16 in ICU setting (n = 2857) 28 in cardiac surgery (n = 3598) | Mixed ICU vs burns vs sepsis/septic shock vs acute pancreatitis VitC alone vs enteral vitC vs IV vitC vs IV vitC > 5 g | ICU patients: X mortality X acute kidney injury X ICU or hospital LOS Cardiac surgery: ↓ postoperative atrial fibrillation ↓ ICU and hospital LOS |
Wang et al. [4] Ann Intensive Care | Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis | P—critically ill patients I—IV vitC (including co-administration of antioxidants) C—placebo or no intervention O—mortality, resuscitation fluid requirement, urine output, acute kidney injury, vasopressor requirement, duration of mechanical ventilation, ICU and/or hospital LOS | 12 RCT, quasi-RCT, observational (n = 1210) | Low dose vs medium dose vs high dose Burn vs sepsis vs others | ↓ mortality (doses of 3–10 g/day) X morality (< 3 g/day or ≥ 10 g/day) ↓ duration of vasopressor support ↓ duration of mechanical ventilation X acute kidney injury X ICU or hospital LOS X fluid requirement X urine output |
Hemila and Chalker [5] | Vitamin C can shorten the length of stay in the ICU: A meta-analysis | P—ICU patients I—vitC C—placebo or none O—ICU LOS, duration of mechanical ventilation | 18 controlled trials (n = 2004) including 13 cardiac surgery | IV vs oral 1–2 days ICU vs 3–5 days ICU > 24 h ventilation vs < 24 h ventilation | ↓ ICU LOS ↓ duration of mechanical ventilation |
Langlois et al. [6] JPEN | Vitamin C supplementation in the critically ill: A systematic review and meta-analysis | P—ICU patients I—vitC (enteral or parenteral) C—placebo or none O—mortality, incident infections, ICU LOS, hospital LOS, duration of mechanical ventilation | 11 RCTs 9 RCTs with mortality (n = 1322) | Low dose vs high dose Combined therapy vs monotherapy Oral/enteral vs parenteral Non-septic vs septic Higher-quality trials vs low-quality trials | X mortality ↓ (trend) mortality (IV high dose vitC monotherapy) X infections X ICU or hospital LOS X duration of mechanical ventilation |
Zhang and Jativa [7] SAGE Open Med | Vitamin C supplementation in the critically ill: A systematic review and meta-analysis | P—critically ill adult patients I—IV vitC C—placebo or no intervention O—mortality, duration of mechanical ventilation, duration of vasopressor support, fluid requirements, urine output | 4 RCTs and 1 retrospective (n = 142) |  | X mortality ↓ need for vasopressor support ↓ duration of mechanical ventilation ↓ (trend) fluid requirements ↑ (trend) urine output |
Li Crit Care [1] | Evidence is stronger than you think: a meta-analysis of vitamin C use in patients with sepsis | P—patients with sepsis I—IV vitC C—placebo or none O—mortality, ICU LOS, vasopressor duration | 2 RCTs and 1 before-after |  | ↓ mortality X ICU LOS ↓ vasopressor duration |
Lin et al. [8] Open J Intern Med | Adjuvant administration of vitamin C improves mortality of patients with sepsis and septic shock: A systems review and meta-analysis | P—patients with septic shock and severe sepsis I—vitC C—placebo O—mortality | 4 RCTs and 2 retrospective studies (n = 109) | RCT vs retrospective High dose vs low dose | X mortality ↓ mortality (doses of > 50 mg/kg/day) X ICU LOS |